Associate Professor in Experimental and Clinical Pharmacology, University of Minnesota

Marnie Peterson works on characterization of interactions between microbes such as Staphylococcus aureus and mucosal surfaces for the development of novel drug therapies including topical microbicides, anti-inflammatory agents as well as mucosal vaccine strategies. Learn more about Dr. Peterson's work by reading International Innovation-Healthcare's "Tackling Staphylococcal exotoxins" (PDF).

She also looks a staphylococcal pathogenesis for the treatment and prevention of Staphylococcal Infections & Toxic Shock Syndrome. Staphylococcal exoproteins (hemolysins and superantigens) activate pro-inflammatory mechanisms of epithelial cells, which promotes toxin-mediated diseases Development of a Topical Microbicides: dual acting antimicrobial and antiinflammatory agents for treatment of infections and promotion of wound healing.

Experience

  • –present
    Associate Professor in Experimental and Clinical Pharmacology, University of Minnesota